| Bruce Lovins, MD | |
|
1613 N Mckenzie St, Foley, AL 36535-2247 | |
| (251) 949-3710 | |
| (251) 949-3715 |
| Full Name | Bruce Lovins |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 1613 N Mckenzie St, Foley, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538260724 | NPI | - | NPPES |
| 208420 | Medicaid | AL | |
| 51191838 | Other | AL | BCBS AL |
| 08625804 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD.32384 (Alabama) | Secondary |
| 207Q00000X | Family Medicine | MD.32384 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Baldwin Regional Medical Center | Foley, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foley Clinic Corp. | 5193741759 | 84 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
Reuters reports these agreements are not likely to be signed until mid-September. Also in the news, the race is on to train navigators while, in Washington state, Group Health makes a decision about abortion coverage in exchange plans. And Republicans on Capitol Hill offer a new plan for insuring government officials.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
A compound isolated from a cyanobacterium, a type of blue-green algae known as Nostoc, shows promise of becoming a natural drug candidate for fighting Alzheimer's and other neurodegenerative diseases, according to an in vitro study by researchers in Switzerland.
› Verified 5 days ago
| Entity Name | Whatley Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063422756 PECOS PAC ID: 8224921705 Enrollment ID: O20040206000846 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
Reuters reports these agreements are not likely to be signed until mid-September. Also in the news, the race is on to train navigators while, in Washington state, Group Health makes a decision about abortion coverage in exchange plans. And Republicans on Capitol Hill offer a new plan for insuring government officials.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
A compound isolated from a cyanobacterium, a type of blue-green algae known as Nostoc, shows promise of becoming a natural drug candidate for fighting Alzheimer's and other neurodegenerative diseases, according to an in vitro study by researchers in Switzerland.
› Verified 5 days ago
| Entity Name | Foley Clinic Corp. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629027826 PECOS PAC ID: 5193741759 Enrollment ID: O20051021000930 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
Reuters reports these agreements are not likely to be signed until mid-September. Also in the news, the race is on to train navigators while, in Washington state, Group Health makes a decision about abortion coverage in exchange plans. And Republicans on Capitol Hill offer a new plan for insuring government officials.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
A compound isolated from a cyanobacterium, a type of blue-green algae known as Nostoc, shows promise of becoming a natural drug candidate for fighting Alzheimer's and other neurodegenerative diseases, according to an in vitro study by researchers in Switzerland.
› Verified 5 days ago
| Entity Name | Moore Physician Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336647098 PECOS PAC ID: 8820350911 Enrollment ID: O20180330000629 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
Reuters reports these agreements are not likely to be signed until mid-September. Also in the news, the race is on to train navigators while, in Washington state, Group Health makes a decision about abortion coverage in exchange plans. And Republicans on Capitol Hill offer a new plan for insuring government officials.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
A compound isolated from a cyanobacterium, a type of blue-green algae known as Nostoc, shows promise of becoming a natural drug candidate for fighting Alzheimer's and other neurodegenerative diseases, according to an in vitro study by researchers in Switzerland.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce Lovins, MD 1613 N Mckenzie St, Foley, AL 36535-2247 Ph: (251) 949-3749 | Bruce Lovins, MD 1613 N Mckenzie St, Foley, AL 36535-2247 Ph: (251) 949-3710 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
Reuters reports these agreements are not likely to be signed until mid-September. Also in the news, the race is on to train navigators while, in Washington state, Group Health makes a decision about abortion coverage in exchange plans. And Republicans on Capitol Hill offer a new plan for insuring government officials.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
A compound isolated from a cyanobacterium, a type of blue-green algae known as Nostoc, shows promise of becoming a natural drug candidate for fighting Alzheimer's and other neurodegenerative diseases, according to an in vitro study by researchers in Switzerland.
› Verified 5 days ago
Carol Patricia Motley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1851 N Mckenzie St Ste 101, Foley, AL 36535 Phone: 251-424-1232 Fax: 251-424-1954 | |
Jimmy Steven Hankins, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 W Laurel Ave, Foley, AL 36535 Phone: 251-943-5440 Fax: 251-943-5404 | |
Gregory W Jones, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1851 N Mckenzie St Ste 101, Foley, AL 36535 Phone: 251-424-1232 Fax: 251-424-1954 | |
Eric S Cheung, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1518 N Mckenzie St, Suite 400, Foley, AL 36535 Phone: 251-424-1130 Fax: 251-424-1131 | |
Dr. Ian Scott Gilson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1851 N Mckenzie St Ste 206, Foley, AL 36535 Phone: 251-677-6810 Fax: 251-677-6811 | |
Dr. Timothy Francis Mott, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1851 N Mckenzie St Ste 101, Foley, AL 36535 Phone: 251-424-1232 Fax: 251-424-1954 | |
Dr. Janet L. Hoffman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1613 N Mckenzie St, Foley, AL 36535 Phone: 251-949-3710 Fax: 251-949-3715 |